• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Castle Biosciences, Inc. - Common stock (NQ:CSTL)

    27.91 -0.26 (-0.92%)
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 419,930
    Open 27.67
    Bid (Size) 23.16 (100)
    Ask (Size) 28.60 (200)
    Prev. Close 28.17
    Today's Range 27.17 - 28.58
    52wk Range 14.59 - 44.28
    Shares Outstanding 25,167,365
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    This $56 Million Sale Slashed One Fund's DigitalBridge Stake Amid 49% Stock Surge ↗
    DigitalBridge Group operates at the forefront of digital infrastructure, managing assets critical to global connectivity and data growth. 
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    This Fund Just Disclosed a $29 Million Sale of a Beauty Stock Up 20% This Past Year ↗
    e.l.f. Beauty delivers cosmetics and skin care through a multi-channel model, with recent filings highlighting strong revenue growth. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    -27.6%
    -27.6%
    1 Month
    -28.3%
    -28.3%
    3 Month
    -29.6%
    -29.6%
    6 Month
    +20.9%
    +20.9%
    1 Year
    +30.9%
    +30.9%

    More News

    Read More
    News headline image
    What's Behind This $32 Million Bet on Baidu Amid a 36% Stock Rally? ↗
    Via The Motley Fool
    Topics Artificial Intelligence Economy Regulatory Compliance
    Castle Biosciences Inc (NASDAQ:CSTL) Reports Q4 2025 Revenue Beat Amid Profitability Transition ↗
    Via Chartmill
    News headline image
    Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences (CSTL) Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Castle Biosciences Reports Fourth Quarter and Full–Year 2025 Results
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Prospective Validation Study in JAAD Demonstrates Castle Biosciences’ AdvanceAD-Tx™ Test Identifies Patients More Likely to Achieve Faster and Deeper Responses with JAK Inhibitor Therapy in Moderate-to-Severe Atopic Dermatitis
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences to Release Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call on Thursday, Feb. 26, 2026
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    AIGH Capital Dumps 1.1 Million MaxLinear (MXL) Shares ↗
    Via The Motley Fool
    A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen) ↗
    Via Chartmill
    News headline image
    CS Diagnostics (OTCQB: CSDX) Advances Infection Control and Oncology Innovation Plus – IVP, SAFX, JTAI, OCG, BMXI Inside
    Via AB Newswire
    Topics Intellectual Property
    News headline image
    Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full–Year 2025 Results
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Landmark Study Shows Combination of Castle Biosciences' DecisionDx®-UM and PRAME Outperforms Gene Mutation Analysis in Predicting Survival Outcomes in Uveal Melanoma
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Systematic Review and Meta-Analysis Confirms TissueCypher® Outperforms Traditional Pathology or Clinical Factors Alone to Identify Patients at Increased Risk of Developing Esophageal Cancer
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Expert Melanoma Panel Recommends Castle Biosciences’ DecisionDx®-Melanoma as a Best-Practice Tool for Managing Patients with Melanoma
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences Earns a Houston Chronicle Top Workplaces Award for the Fifth Consecutive Year
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
    From Castle Biosciences, Inc.
    Via GlobeNewswire
    News headline image
    Why Castle Biosciences' Rally Might Just Be Getting Started ↗
    Via Benzinga
    News headline image
    AMD To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
    Via Benzinga
    News headline image
    Castle Biosciences Reports Third Quarter 2025 Results
    From Castle Biosciences, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Castle Biosciences, Inc. - Common stock publicly traded?
    Yes, Castle Biosciences, Inc. - Common stock is publicly traded.
    What exchange does Castle Biosciences, Inc. - Common stock trade on?
    Castle Biosciences, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Castle Biosciences, Inc. - Common stock?
    The ticker symbol for Castle Biosciences, Inc. - Common stock is CSTL on the Nasdaq Stock Market
    What is the current price of Castle Biosciences, Inc. - Common stock?
    The current price of Castle Biosciences, Inc. - Common stock is 27.91
    When was Castle Biosciences, Inc. - Common stock last traded?
    The last trade of Castle Biosciences, Inc. - Common stock was at 03/05/26 04:00 PM ET
    What is the market capitalization of Castle Biosciences, Inc. - Common stock?
    The market capitalization of Castle Biosciences, Inc. - Common stock is 702.42M
    How many shares of Castle Biosciences, Inc. - Common stock are outstanding?
    Castle Biosciences, Inc. - Common stock has 702M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.